StockData
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME) stock

PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.84−0.35 (-8.35%)

Close on Nov 17, 2026Market cap $696.49MP/E –Yield –

Prime Medicine price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Prime Medicine's price to book ratio was 19.5× on Nov 11, 2026, against 4.3× a year earlier. Over the last 4 years it ranged from 1.4× to 21.4×, with a median of 4.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202619.5×+15.7
2025Dec 31, 20253.9×+1.8
2024Dec 31, 20242.0×−2.4
2023Dec 29, 20234.4×–

More Prime Medicine figures

See a number that looks wrong?